BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

215 related articles for article (PubMed ID: 26494948)

  • 21. Clinicopathological factors affecting survival and recurrence after initial hepatectomy in non-B non-C hepatocellular carcinoma patients with comparison to hepatitis B or C virus.
    Okuda Y; Mizuno S; Shiraishi T; Murata Y; Tanemura A; Azumi Y; Kuriyama N; Kishiwada M; Usui M; Sakurai H; Tabata M; Yamada T; Isaji S
    Biomed Res Int; 2014; 2014():975380. PubMed ID: 24745029
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Comparison of clinicopathologic characteristics among patients with HBV-positive, HCV-positive and Non-B Non-C hepatocellular carcinoma after hepatectomy: a systematic review and meta-analysis.
    Yu B; Zhi X; Li Q; Li T; Chen Z
    BMC Gastroenterol; 2023 Aug; 23(1):289. PubMed ID: 37612653
    [TBL] [Abstract][Full Text] [Related]  

  • 23. [Compliance and problems with the surveillance program for HCC diagnosis].
    Okano JI; Matsuki Y; Nagahara R; Yamane M; Okamoto T; Miyoshi KI; Matono T; Ohyama K; Hosho K; Isomoto H
    Nihon Shokakibyo Gakkai Zasshi; 2017; 114(7):1255-1263. PubMed ID: 28679981
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Clinicopathologic study on hepatocellular carcinoma negative for hepatitis B surface antigen and antibody to hepatitis C virus.
    Noguchi K; Nakashima O; Nakashima Y; Shiota K; Nawata H; Kojiro M
    Int J Mol Med; 2000 Dec; 6(6):661-5. PubMed ID: 11078825
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Comparison of the clinical characteristics among hepatocellular carcinoma of hepatitis B, hepatitis C and non-B non-C patients.
    Dohmen K; Shigematsu H; Irie K; Ishibashi H
    Hepatogastroenterology; 2003; 50(54):2022-7. PubMed ID: 14696457
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Prognostic impact of hepatectomy for patients with non-hepatitis B, non-hepatitis C hepatocellular carcinoma.
    Ochiai T; Ogino S; Ishimoto T; Toma A; Yamamoto Y; Morimura R; Ikoma H; Otsuji E
    Anticancer Res; 2014 Aug; 34(8):4399-410. PubMed ID: 25075077
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Clinical characteristics of non-B non-C hepatocellular carcinoma: a single-center retrospective study.
    Kim SK; Marusawa H; Eso Y; Nishikawa H; Ueda Y; Kita R; Kimura T; Chiba T; Osaki Y; Kudo M
    Digestion; 2011; 84 Suppl 1():43-9. PubMed ID: 22156485
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Characteristics and prognosis of patients in Japan with viral marker-negative hepatocellular carcinoma.
    Toyoda H; Kumada T; Kiriyama S; Sone Y; Tanikawa M; Hisanaga Y; Kanamori A; Yamaguchi A; Isogai M; Kaneoka Y; Washizu J
    J Gastroenterol Hepatol; 2008 Mar; 23(3):459-66. PubMed ID: 17854425
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Potential etiology, prevalence of cirrhosis, and mode of detection among patients with non-B non-C hepatocellular carcinoma in Korea.
    Kim J; Kang W; Sinn DH; Gwak GY; Paik YH; Choi MS; Lee JH; Koh KC; Paik SW
    Korean J Intern Med; 2020 Jan; 35(1):65-78. PubMed ID: 31189301
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Treatment outcomes after radiofrequency ablation in patients with non-B non-C hepatocellular carcinoma within Milan criteria: comparison with HBV-related hepatocellular carcinoma.
    Liu B; Tan Y; Shen H; Wang L; Huang G; Huang T; Long H; Xie X; Xie X
    Int J Hyperthermia; 2023; 40(1):2244207. PubMed ID: 37580046
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Liver transplantation for hepatitis B virus: Decreasing indication and changing trends.
    Al-Hamoudi W; Elsiesy H; Bendahmash A; Al-Masri N; Ali S; Allam N; Al Sofayan M; Al Bahili H; Al Sebayel M; Broering D; Saab S; Abaalkhail F
    World J Gastroenterol; 2015 Jul; 21(26):8140-7. PubMed ID: 26185387
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Comparison of clinical manifestations and outcomes between hepatitis B virus- and hepatitis C virus-related hepatocellular carcinoma: analysis of a nationwide cohort.
    Sinn DH; Gwak GY; Cho J; Paik SW; Yoo BC
    PLoS One; 2014; 9(11):e112184. PubMed ID: 25372403
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Differences in surgical outcomes between hepatitis B- and hepatitis C-related hepatocellular carcinoma: a retrospective analysis of a single North American center.
    Franssen B; Alshebeeb K; Tabrizian P; Marti J; Pierobon ES; Lubezky N; Roayaie S; Florman S; Schwartz ME
    Ann Surg; 2014 Oct; 260(4):650-6; discussion 656-8. PubMed ID: 25203882
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Non-B, non-C hepatocellular carcinoma (Review).
    Nishikawa H; Osaki Y
    Int J Oncol; 2013 Nov; 43(5):1333-42. PubMed ID: 23969900
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Liver Transplantation for Non-B and Non-C Hepatocellular Carcinoma.
    Kaido T; Mori A; Ogura Y; Hata K; Yoshizawa A; lida T; Yagi S; Uemoto S
    Hepatogastroenterology; 2015 Jun; 62(140):933-6. PubMed ID: 26902031
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Factors that affect efficacy of ultrasound surveillance for early stage hepatocellular carcinoma in patients with cirrhosis.
    Del Poggio P; Olmi S; Ciccarese F; Di Marco M; Rapaccini GL; Benvegnù L; Borzio F; Farinati F; Zoli M; Giannini EG; Caturelli E; Chiaramonte M; Trevisani F;
    Clin Gastroenterol Hepatol; 2014 Nov; 12(11):1927-33.e2. PubMed ID: 24582947
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Inter-alpha-trypsin inhibitor heavy chain H4 as a diagnostic and prognostic indicator in patients with hepatitis B virus-associated hepatocellular carcinoma.
    Noh CK; Kim SS; Kim DK; Lee HY; Cho HJ; Yoon SY; Lee GH; Hyun SA; Kim YJ; Kim HJ; Hwang JA; Ahn SJ; Shin SJ; Lee KM; Yoo BM; Cho SW; Cheong JY
    Clin Biochem; 2014 Sep; 47(13-14):1257-61. PubMed ID: 24836184
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Possible contribution of prior hepatitis B virus infection to the development of hepatocellular carcinoma.
    Tanaka H; Iwasaki Y; Nouso K; Kobayashi Y; Nakamura S; Matsumoto E; Toshikuni N; Kaneyoshi T; Ohsawa T; Takaguchi K; Fujio K; Senoh T; Ohnishi T; Sakaguchi K; Shiratori Y
    J Gastroenterol Hepatol; 2005 Jun; 20(6):850-6. PubMed ID: 15946131
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Semiannual surveillance is superior to annual surveillance for the detection of early hepatocellular carcinoma and patient survival.
    Santi V; Trevisani F; Gramenzi A; Grignaschi A; Mirici-Cappa F; Del Poggio P; Di Nolfo MA; Benvegnù L; Farinati F; Zoli M; Giannini EG; Borzio F; Caturelli E; Chiaramonte M; Bernardi M;
    J Hepatol; 2010 Aug; 53(2):291-7. PubMed ID: 20483497
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Impact of occult hepatitis B virus infection on outcome after resection for non-B non-C hepatocellular carcinoma.
    Wu ZF; Xu Z; Li WS; Zhang HB; Yang N; Yao XQ; Liu FK; Yang GS
    J Surg Res; 2015 Jan; 193(1):153-60. PubMed ID: 25128925
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.